Verano Holdings (VRNO) Shares Outstanding (Weighted Average) (2021 - 2026)

Verano Holdings (VRNO) reported Shares Outstanding (Weighted Average) of $363.4 million for Q1 2026, up 1.18% year-over-year from $359.1 million in Q1 2025, and up 0.68% quarter-over-quarter from $360.9 million in Q4 2025.

Verano Holdings (VRNO) Shares Outstanding (Weighted Average) (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $363.4 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $363.4 million, up 1.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $363.4 million (up 1.18% YoY), and the FY2025 annual result was $360.9 million, up 3.24% from the prior year.
  • Shares Outstanding (Weighted Average) grew to $363.4 million in Q1 2026 per VRNO's latest filing, from $360.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $363.4 million in Q1 2026 and troughed at $326.3 million in Q1 2022.
  • A 5-year average of $346.1 million and a median of $344.1 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) advanced 23.16% in 2022, then increased 0.76% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $331.4 million in 2022, then rose by 3.43% to $342.8 million in 2023, then grew by 1.99% to $349.6 million in 2024, then rose by 3.24% to $360.9 million in 2025, then rose by 0.68% to $363.4 million in 2026.
  • Business Quant data shows VRNO's Shares Outstanding (Weighted Average) at $363.4 million in Q1 2026, $360.9 million in Q4 2025, and $361.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Verano Holdings - - 98.98 Mn 363.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 363.37 Mn
Dec 31, 2025 360.91 Mn
Sep 30, 2025 361.79 Mn
Jun 30, 2025 359.76 Mn
Mar 31, 2025 359.15 Mn
Dec 31, 2024 349.58 Mn
Sep 30, 2024 351.17 Mn
Jun 30, 2024 345.48 Mn
Mar 31, 2024 344.08 Mn
Dec 31, 2023 342.77 Mn
Sep 30, 2023 343.43 Mn
Jun 30, 2023 342.53 Mn
Mar 31, 2023 341.48 Mn
Dec 31, 2022 331.41 Mn
Sep 30, 2022 332.87 Mn
Jun 30, 2022 327.40 Mn
Mar 31, 2022 326.29 Mn
Dec 31, 2021 290.44 Mn
Sep 30, 2021 303.83 Mn
Jun 30, 2021 265.84 Mn